
Targeting the pathway of GSK-3β/nerve growth factor to attenuate post-infarction arrhythmias by preconditioned adipose-derived stem cells
Keywords: α-SMA; α-smooth muscle cell actin; ADSC; adipose-derived stem cell; BP; n-butylidenephthalide; DHE; dihydroethidium; GSK-3β; glycogen synthase kinase-3β; hADSCs; human adipose-derived stem cells; MI; myocardial infarction; NGF; nerve growth factor; PI